Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome

[1]  Wen Yin,et al.  Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, medRxiv.

[2]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[3]  Zhaofeng Chen,et al.  Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.

[4]  Michael Roth,et al.  Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? , 2020, The Lancet Respiratory Medicine.

[5]  Bo Li,et al.  Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China , 2020, Clinical Research in Cardiology.

[6]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[7]  Ritesh Gupta,et al.  Clinical considerations for patients with diabetes in times of COVID-19 epidemic , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[8]  Qiurong Ruan,et al.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.

[9]  W. Tu,et al.  Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit , 2020, Intensive Care Medicine.

[10]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[11]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[12]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[13]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[14]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[15]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[16]  Ning Zhang,et al.  The effect of diabetes on the risk and mortality of acute lung injury/acute respiratory distress syndrome , 2019, Medicine.

[17]  D. Cook,et al.  Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study , 2018, Diabetes Care.

[18]  Derek G Cook,et al.  Diabetes and infection: assessing the association with glycaemic control in population-based studies. , 2016, The lancet. Diabetes & endocrinology.

[19]  A. Farcomeni,et al.  Hospitalization for Pneumonia is Associated With Decreased 1-Year Survival in Patients With Type 2 Diabetes , 2016, Medicine.

[20]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[21]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[22]  B. Nordestgaard,et al.  Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome , 2007, Diabetologia.